Insights

Gathering insights about PTG…

Similar companies to PTG

PTG Tech Stack

PTG uses 8 technology products and services including oEmbed, Microsoft Excel, Epicor, and more. Explore PTG's tech stack below.

oEmbed
Dev Tools
Microsoft Excel
Editors
Epicor
Enterprise Resource Planning
Font Awesome
Font Scripts
Microsoft Word
Office Suites
LinkedIn
Online Community Software
PHP
Programming Languages
Google Analytics
Web Analytics

Media & News

Protagonist Therapeutics, Inc. $PTGX Stock Holdings Trimmed by Aviva PLC
Aviva PLC lowered its position in shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX) by 28.5% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,435 shares of the company's stock after selling 3,765 shares during the quarter. Aviva PLC's holdings in Protagonist
Nov 14, 2025 | www.defenseworld.net
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.54 per share a year ago.
Nov 06, 2025 | www.zacks.com
Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to the U.S. FDA in July, the European Medicines Agency (EMA) application was submitted in September Rusfertide granted breakthrough designation for patients in Polycythemia Vera (PV) and the subject of four presentations including 52-week results of the VERIFY Phase 3 Study at ASH, the 67th Annual American Society of Hematology (ASH) meeting in December First patient dosed in the Phase 1 trial of PN-881, a first-in-class oral IL-17 peptide antagonist IND-enabling studies progressing as planned with triple-GLP/GIP/GCG agonists PN-477sc and PN-477o Oral hepcidin development candidate expected to be nominated by year end Cash, cash equivalents and marketable securities of $678.8 million as of September 30, 2025, anticipated to provide cash runway through at least end of 2028 NEWARK, CA / ACCESS Newswire / November 6, 2025 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the third quarter ended September 30, 2025, and provided a corporate update. "2025 continues to be a highly productive year with significant accomplishments in both partnered and wholly owned programs," said Dinesh V.
Nov 06, 2025 | www.accessnewswire.com
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four presentations at the 67th Annual American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida, from December 6-9, 2025. ASH Presentation Details: Presenting Author: Andrew Kuykendall, MD (Moffitt Cancer Center) Publication Number: 81 Title: Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study Oral Session Name: 634.
Nov 03, 2025 | www.accessnewswire.com
Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy?
Protagonist Therapeutics (PTGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 30, 2025 | www.zacks.com
Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal
PTGX shares jump 30% after reports that J&J is in talks to acquire the biotech firm amid ongoing negotiations.
Oct 13, 2025 | www.zacks.com
Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make
Johnson & Johnson (JNJ) is rumored to be in talks to acquire Protagonist Therapeutics (PTGX), following significant buyout speculation and a 30% PTGX stock surge. PTGX's value is underpinned by its oral immunology drug icotrokinra and blockbuster potential of rusfertide for polycythemia vera, both with strong partnership structures. A JNJ acquisition could save milestone payments, secure future royalties, and add derisked, late-stage assets to JNJ's portfolio, supporting long-term growth.
Oct 12, 2025 | seekingalpha.com

PTG's Email Address Formats

PTG uses at least 1 format(s):

PTG Email Formats	Example	Percentage
FLast@parkertrutec.com	JDoe@parkertrutec.com	48%
Last.First@parkertrutec.com	Doe.John@parkertrutec.com	2%
FLast@parkertrutec.com	JDoe@parkertrutec.com	48%
Last.First@parkertrutec.com	Doe.John@parkertrutec.com	2%

Frequently Asked Questions

Where is PTG's headquarters located?

PTG's main headquarters is located at 4795 Upper Valley Pike, Urbana, Ohio 43078, US. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is PTG's stock symbol?

PTG is a publicly traded company; the company's stock symbol is PTGX.

What is PTG's official website and social media links?

PTG's official website is parkertrutec.com and has social profiles on LinkedIn.

What is PTG's NAICS code?

PTG's NAICS code is 3361 - Motor Vehicle Manufacturing.

How many employees does PTG have currently?

As of October 2025, PTG has approximately 230 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Of Strategy And Operations: O. A.President: J. P.Owner: A. K.. Explore PTG's employee directory with LeadIQ.

What industry does PTG belong to?

PTG operates in the Motor Vehicle Manufacturing industry.

What technology does PTG use?

PTG's tech stack includes oEmbedMicrosoft ExcelEpicorFont AwesomeMicrosoft WordLinkedInPHPGoogle Analytics.

What is PTG's email format?

PTG's email format typically follows the pattern of FLast@parkertrutec.com. Find more PTG email formats with LeadIQ.

When was PTG founded?

PTG was founded in 1988.

PTG

Q: What is PTG's official website and social media links?

PTG's official website is parkertrutec.com. PTG has social profiles on LinkedIn.

Q: How many employees does PTG have currently?

PTG has approximately 230 employees.

Q: What technology does PTG use?

PTG's tech stack includes JSON-LD, MySQL, X-Content-Type-Options, TrackJS, mOxie.

Motor Vehicle ManufacturingUnited States201-500 Employees

Welcome! Our company, Parker Trutec Inc., with the support of our overseas group companies, has been providing coating and heat treatment services in North America, with proven results, for nearly 30 years.

We are confident that we will be able to design a process based on your specifications to provide stable coating and heat treatment quality. Our management team will work together to satisfy you in four areas: quality, delivery, cost, and service. We request you to strongly consider using our service.

Joseph Gummel,
President
Parker Trutec Inc.

Company Overview

Headquarters: 4795 Upper Valley Pike, Urbana, Ohio 43078, US
Website: parkertrutec.com
Stock Symbol: PTGX
NAICS Code: 3361 - Motor Vehicle Manufacturing
Founded: 1988
Employees: 201-500

Media & News

Funding & Financials

$25M$50M
PTG's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
PTG's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to PTG

Andreessen Horowitz

Battery Ventures

Founders Fund

Khosla Ventures

Sequoia Capital

Bessemer Venture Partners

500 Startups

Nea

First Round Capital

Y Combinator

Accel

Innovation Works

PTG Tech Stack

Media & News

Protagonist Therapeutics, Inc. $PTGX Stock Holdings Trimmed by Aviva PLC

Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates

Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting

Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy?

Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal

Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make

PTG's Email Address Formats

Frequently Asked Questions

Where is PTG's headquarters located?

What is PTG's stock symbol?

What is PTG's official website and social media links?

What is PTG's NAICS code?

How many employees does PTG have currently?

What industry does PTG belong to?

What technology does PTG use?

What is PTG's email format?

When was PTG founded?

PTG

Company Overview

Media & News

Protagonist Therapeutics, Inc. $PTGX Stock Holdings Trimmed by Aviva PLC

Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates

Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?